TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.30$ -0.4% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Zhengye Biotechnology Holding Limited (ZYBT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 13.2% of the shares are freely tradable; institutional investors hold 0.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 0.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 16.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 13.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 47Mio.

Largest Shareholders

Institutions

Institutions ZYBT
Name Stake (%) Shares Change (%) Date
XTX Topco Ltd 0.09 44,146 -25.5 03/31/2026
Geode Capital Management, LLC 0.06 29,068 +0.0 03/31/2026
Winton Capital Group Ltd 0.03 12,730 -61.9 06/30/2026
UBS Group AG 0.02 8,036 -11.8 03/31/2026
Tower Research Capital LLC 0.01 4,912 +122.6 03/31/2026
Royal Bank of Canada 0.00 1,230 +0.0 03/31/2026
Morgan Stanley - Brokerage Accounts 0.00 261 -83.8 03/31/2026

Funds

Funds ZYBT
Name Stake (%) Shares Change (%) Date
Fidelity Nasdaq Composite Index 0.06 29,068 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?